Scientific standards for studies on modified risk tobacco products / Committee on Scientific Standards for Studies on Modified Risk Tobacco Products, Board on Population Health and Public Health Practice, Institute of Medicine of the National Academies.
Material type:![Text](/opac-tmpl/lib/famfamfam/BK.png)
- text
- computer
- online resource
- 9780309223997
- 0309223997
- 1280380225
- 9781280380228
- United States Family Smoking Prevention and Tobacco Control Act
- Research -- Standards -- United States
- Tobacco products -- Risk assessment -- Research -- United States
- Tobacco use -- Health aspects -- Research -- United States
- Products liability -- Tobacco -- Research -- United States
- Nicotine addiction -- Research -- United States
- Recherche -- Normes -- États-Unis
- Produits du tabac -- Évaluation du risque -- Recherche -- États-Unis
- Responsabilité du fait des produits -- Tabac -- Recherche -- États-Unis
- Tabagisme -- Recherche -- États-Unis
- HEALTH & FITNESS -- Diseases -- Nervous System (incl. Brain)
- MEDICAL -- Neurology
- Research -- Standards
- United States
- 616.86/5 23
- RC567
- 2012 E-070
- WM 290
Item type | Home library | Collection | Call number | Materials specified | Status | Date due | Barcode | |
---|---|---|---|---|---|---|---|---|
![]() |
OPJGU Sonepat- Campus | E-Books EBSCO | Available |
Includes bibliographical references.
Introduction -- Governance and conduct of studies -- Evidence base and methods for studying health effects -- Methods for investigating addictive potential -- Methods for studying risk perception and risk communication -- Decision making and oversight of MRTP studies : findings and recommendations.
"Smoking-related diseases kill more Americans than alcohol, illegal drugs, murder and suicide combined. The passage of the Family Smoking Prevention and Tobacco Control Act of 2009 gave the FDA authority to regulate "modified risk tobacco products" (MRTPs), tobacco products that are either designed or advertised to reduce harm or the risk of tobacco-related disease. MRTPs must submit to the FDA scientific evidence to demonstrate the product has the potential to reduce tobacco related harms as compared to conventional tobacco products. The IOM identifies minimum standards for scientific studies that an applicant would need to complete to obtain an order to market the product from the FDA."--Publisher's description.
Print version record.
eBooks on EBSCOhost EBSCO eBook Subscription Academic Collection - Worldwide
There are no comments on this title.